Influence of low-dose acetylsalicylacid on the treatment result of patients with pneumonia (benefit of ASS with CAP) - a retrospective data analysis

Influence of low-dose acetylsalicylacid on the treatment result of patients with pneumonia (benefit of ASS with CAP) - a retrospective data analysis - BACAP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00007626

Enrollment

365

Registered

2015-02-05

Start date

2013-04-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J18 R65 A41 R57.2

Interventions

Group 1: patients without low-dose acetylsalicylic acid therapy, retrospective data analysis Group 2: patients with low-dose acetylsalicylic acid permanent therapy, retrospective data analysis Group 3

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pneumonia

Exclusion criteria

Exclusion criteria: 1. hospital stay <4 days; 2. transfer from another hospital; 3. pregnancy; 4. diagnosis of lung cancer; 5. diagnosis of tuberculosis

Design outcomes

Primary

Measure	Time frame
1. mortality during hospital stay; 2. Organ failure (incl. considering pre-existing organ dysfunctions) in the time period concerned; 3. occurence of SIRS or sepsis or septic shock	—

Secondary

Measure	Time frame
1. duration (days) of hospital and ICU stay considering geriatric treatments; 2. occurence of haemostaseologic and bleeding complications; 3. maximum for APACHE II and SOFA score of ICU patients	—

Countries

Germany

Contacts

Public ContactJohannes Winning

Universitätsklinikum JenaKlinik für Anästhesie und Intensivmedizin

Johannes.Winning@med.uni-jena.de++49 (0) 3641 9323177

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026